Investigation of release and degradation of cardiac troponin T in patients with acute myocardial infarction

Clinical Biochemistry

Volumn 40, Issue 12, 2007, Pages 851-855

  Michielsen, Etienne C H J ^a   Diris, Jart H C ^a   Kleijnen, Vincent W V C ^a   Wodzig, Will K W H ^a   Van Dieijen Visser, Marja P ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Coronary arteriosclerosis; Myocardial ischemia; Proteases; Troponin T

Indexed keywords

TROPONIN T;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL ARTICLE; HEART MUSCLE REVASCULARIZATION; HUMAN; IMMUNOASSAY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN SECRETION; WESTERN BLOTTING;

HUMANS; MOLECULAR WEIGHT; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TROPONIN T;

EID: 34447544184     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.04.004     Document Type: Article

References (30)

1. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 36 3 (2000 (Sep.)) 959-969
2. Labugger R., Organ L., Collier C., Atar D., and Van Eyk J.E. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 102 11 (2000) 1221-1226
3. Morjana N.A. Degradation of human cardiac troponin I after myocardial infarction. Biotechnol. Appl. Biochem. 28 Pt. 2 (1998) 105-111
4. Katrukha A.G., Bereznikova A.V., Filatov V.L., et al. Degradation of cardiac troponin I: implication for reliable immunodetection. Clin. Chem. 44 12 (1998 (Dec.)) 2433-2440
5. Shi Q., Ling M., Zhang X., et al. Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays. Clin. Chem. 45 7 (1999) 1018-1025
6. Panteghini M., Pagani F., Yeo K.T., et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin. Chem. 50 2 (2004 (Feb.)) 327-332
7. Panteghini M. The new definition of myocardial infarction and the impact of troponin determination on clinical practice. Int. J. Cardiol. 106 3 (2006 (Jan. 26)) 298-306
8. Wu A.H., Feng Y.J., Moore R., et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin. Chem. 44 6 Pt. 1 (1998) 1198-1208
9. Michielsen E.C., Diris J.H., Hackeng C.M., Wodzig W.K., and Van Dieijen-Visser M.P. Highly sensitive immunoprecipitation method for extracting and concentrating low-abundance proteins from human serum. Clin. Chem. 51 1 (2005 (Jan.)) 222-224
10. Ricchiuti V., Voss E.M., Ney A., Odland M., Anderson P.A., and Apple F.S. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin. Chem. 44 9 (1998) 1919-1924
11. Davis G.K., Labugger R., Van Eyk J.E., and Apple F.S. Cardiac troponin T is not detected in western blots of diseased renal tissue. Clin. Chem. 47 4 (2001) 782-783
12. Fahie-Wilson M.N., Carmichael D.J., Delaney M.P., Stevens P.E., Hall E.M., and Lamb E.J. Cardiac troponin T circulates in the free, intact form in patients with kidney failure. Clin. Chem. 52 3 (2006 (March 1)) 414-420
13. Katus H.A., Remppis A., Looser S., Hallermeier K., Scheffold T., and Kubler W. Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J. Mol. Cell. Cardiol. 21 (1989) 1349-1353
14. Katus H.A., Remppis A., Scheffold T., Diederich K.W., and Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am. J. Cardiol. 67 (1991 (Jun. 15)) 1360-1367
15. Remppis A., Scheffold T., Greten J., et al. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J. Mol. Cell. Cardiol. 27 2 (1995) 793-803
16. Bunk D.M., and Welch M.J. Characterization of a new certified reference material for human cardiac troponin I. Clin. Chem. 52 2 (2006 (Feb.)) 212-219
17. Apple F.S., and Murakami M.M. Serum 99th percentile reference cutoffs for seven cardiac troponin assays. Clin. Chem. 50 8 (2004 (Aug.)) 1477-1479
18. Fahie-Wilson M.N., Hall E.M., and Lamb E.J. The authors of the article cited above respond. Clin. Chem. 52 12 (2006 (December 1)) 2307-2309
19. Michielsen E.C., Diris J.H., Kleijnen V.W.V.C., Wodzig K.W., and van Dieijen-Visser M.P. Size-exclusion chromatography of circulating cardiac troponin T. Clin. Chem. 52 12 (2006) 2306-2307
20. Michielsen E.C., Diris J.H., Kleijnen V.W.V.C., Wodzig K.W., and Van Dieijen-Visser M.P. Interpretation of cardiac troponin T behaviour in size-exclusion chromatography. Clin. Chem. Lab. Med. 44 12 (2006 (Dec.)) 1422-1427
21. Diris J.H., Hackeng C.M., Kooman J.P., Pinto Y.M., Hermens W.T., and Van Dieijen-Visser M.P. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 109 1 (2004 (Jan. 6)) 23-25
22. Van der Laarse A. Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure. Cardiovasc. Res. 56 1 (2002) 8
23. Lancel S., Joulin O., Favory R., et al. Ventricular myocyte caspases are directly responsible for endotoxin-induced cardiac dysfunction. Circulation 111 20 (2005 (May 24)) 2596-2604
24. Tolnai S., and Korecky B. Calcium-dependent proteolysis and its inhibition in the ischemic rat myocardium. Can. J. Cardiol. 2 1 (1986 (Jan.-Feb.)) 42-47
25. Atsma D.E., Bastiaanse E.M., Jerzewski A., Van der Valk L.J., and Van der Laarse A. Role of calcium-activated neutral protease (calpain) in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition. Circ. Res. 76 6 (1995) 1071-1078
26. Di Lisa F., De Tullio R., and Salamino F. Specific degradation of troponin T and I by mu-calpain and its modulation by substrate phosphorylation. Biochem. J. 308 Pt. 1 (1995 (May 15)) 57-61
27. Gorza L., Menabo R., Vitadello M., Bergamini C.M., and Di Lisa F. Cardiomyocyte troponin T immunoreactivity is modified by cross-linking resulting from intracellular calcium overload. Circulation 93 10 (1996 (May 15)) 1896-1904
28. Barta J., Toth A., Edes I., et al. Calpain-1-sensitive myofibrillar proteins of the human myocardium. Mol. Cell. Biochem. 278 1-2 (2005 (Oct.)) 1-8
29. Communal C., Sumandea M., de Tombe P., Narula J., Solaro R.J., and Hajjar R.J. Functional consequences of caspase activation in cardiac myocytes. Proc. Natl. Acad. Sci. U. S. A. 99 9 (2002) 6252-6256
30. Neumayr G., Pfister R., Mitterbauer G., Eibl G., and Hoertnagl H. Effect of competitive marathon cycling on plasma N-terminal pro-brain natriuretic peptide and cardiac troponin T in healthy recreational cyclists. Am. J. Cardiol. 96 5 (2005 (Sep. 1)) 732-735